Opioid Overdose Risk Following Hospital Discharge Among Individuals Prescribed Long-Term Opioid Therapy: a Risk Interval Analysis

被引:2
|
作者
Lyden, Jennifer R. [1 ,2 ,9 ]
Xu, Stanley [3 ]
Narwaney, Komal J. [4 ]
Glanz, Jason M. [4 ,5 ]
Binswanger, Ingrid A. [4 ,6 ,7 ,8 ]
机构
[1] Denver Hlth, Div Hosp Med, Dept Med, 777 Bannock St, Denver, CO 80204 USA
[2] Univ Colorado, Div Hosp Med, Dept Med, Sch Med, Aurora, CO USA
[3] Kaiser Permanente Southern Calif, Res & Evaluat, Pasadena, CA USA
[4] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[5] Univ Colorado, Dept Epidemiol, Sch Publ Hlth, Aurora, CO USA
[6] Univ Colorado, Dept Med, Div Gen Internal Med, Sch Med, Aurora, CO USA
[7] Colorado Permanente Med Grp, Denver, CO USA
[8] Bernard J Tyson Kaiser Permanente Sch Med, Pasadena, CA USA
[9] Denver Hlth, Div Hosp Med, Dept Med, 777 Bannock St, Denver, CO 80204 USA
关键词
opioid; LTOT; overdose; hospitalization; discharge; VACCINE SAFETY; CHRONIC PAIN; DEATH; ASSOCIATION; RELEASE; GUIDELINES; TRENDS; PRISON;
D O I
10.1007/s11606-022-08014-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundIndividuals prescribed long-term opioid therapy (LTOT) have increased risk of readmission and death after hospital discharge. The risk of opioid overdose during the immediate post-discharge time period is unknown.ObjectiveTo examine the association between time since hospital discharge and opioid overdose among individuals prescribed LTOT.DesignSelf-controlled risk interval analysis.ParticipantsAdults prescribed LTOT with at least one hospital discharge at a safety-net health system and a non-profit healthcare organization in Colorado.Main MeasuresWe identified individuals prescribed LTOT who were discharged from January 2006 through June 2019. The outcome was a composite of fatal and non-fatal opioid overdoses during a 90-day post-discharge observation period, identified using electronic health record (EHR) and vital statistics data. Risk intervals included days 0-6 after index and subsequent hospital discharges. Control intervals ranged from days 7 to 89 after index discharge and included all other time during the observation period that did not fall within a risk interval or time readmitted during a subsequent hospitalization, which was excluded. Poisson regression was used to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI) for overdose events during risk in comparison to control intervals.Key ResultsWe identified 7695 adults (63.3% over 55 years, 59.4% female, 20.3% Hispanic) who experienced 9499 total discharges during the study period. Twenty-one overdoses occurred during their observation periods (1174 per 100,000 person-years [9 in risk, 12 in control]). Overdose risk was significantly higher during the risk interval in comparison to the control interval (IRR 6.92; 95% CI 2.92-16.43).ConclusionDuring the first 7 days after hospital discharge, individuals prescribed LTOT appear to be at elevated risk for opioid overdose. Clarifying mechanisms of overdose risk may help inform in-hospital and post-discharge prevention strategies.
引用
收藏
页码:2560 / 2567
页数:8
相关论文
共 50 条
  • [1] Opioid Overdose Risk Following Hospital Discharge Among Individuals Prescribed Long-Term Opioid Therapy: a Risk Interval Analysis
    Jennifer R. Lyden
    Stanley Xu
    Komal J. Narwaney
    Jason M. Glanz
    Ingrid A. Binswanger
    Journal of General Internal Medicine, 2023, 38 : 2560 - 2567
  • [2] Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy
    Glanz, Jason M.
    Binswanger, Ingrid A.
    Shetterly, Susan M.
    Narwaney, Komal J.
    Xu, Stan
    JAMA NETWORK OPEN, 2019, 2 (04)
  • [3] Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy
    Glanz, Jason M.
    Xu, Stanley
    Narwaney, Komal J.
    Mcclure, David L.
    Rinehart, Deborah J.
    Ford, Morgan A.
    Nguyen, Anh P.
    Binswanger, Ingrid A.
    SUBSTANCE ABUSE, 2023, 44 (03) : 209 - 219
  • [4] Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy
    Jason M. Glanz
    Komal J. Narwaney
    Shane R. Mueller
    Edward M. Gardner
    Susan L. Calcaterra
    Stanley Xu
    Kristin Breslin
    Ingrid A. Binswanger
    Journal of General Internal Medicine, 2018, 33 : 1646 - 1653
  • [5] Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy
    Glanz, Jason M.
    Narwaney, Komal J.
    Mueller, Shane R.
    Gardner, Edward M.
    Calcaterra, Susan L.
    Xu, Stanley
    Breslin, Kristin
    Binswanger, Ingrid A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (10) : 1646 - 1653
  • [6] LONG-TERM OPIOID THERAPY AND OPIOID OVERDOSE IN PATIENTS WITH AND WITHOUT CANCER
    Merlin, Jessica
    Black, Anne
    Lorenz, Karl
    Becker, William
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S121 - S121
  • [7] Defining Risk of Prescription Opioid Overdose: Pharmacy Shopping and Overlapping Prescriptions Among Long-Term Opioid Users in Medicaid
    Yang, Zhuo
    Wilsey, Barth
    Bohm, Michele
    Weyrich, Meghan
    Roy, Kakoli
    Ritley, Dominique
    Jones, Christopher
    Melnikow, Joy
    JOURNAL OF PAIN, 2015, 16 (05): : 445 - 453
  • [8] Update of a Multivariable Opioid Overdose Risk Prediction Model to Enhance Clinical Care for Long-term Opioid Therapy Patients
    Nguyen, Anh P.
    Glanz, Jason M.
    Narwaney, Komal J.
    Zeng, Chan
    Wright, Leslie
    Fairbairn, Lane M.
    Binswanger, Ingrid A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (12) : 2678 - 2685
  • [9] Update of a Multivariable Opioid Overdose Risk Prediction Model to Enhance Clinical Care for Long-term Opioid Therapy Patients
    Anh P. Nguyen
    Jason M. Glanz
    Komal J. Narwaney
    Chan Zeng
    Leslie Wright
    Lane M. Fairbairn
    Ingrid A. Binswanger
    Journal of General Internal Medicine, 2023, 38 : 2678 - 2685
  • [10] Long-Term Opioid Therapy and Risk of Opioid Overdose by Derived Clinical Indication in North Carolina, 2006-2018
    Di Prete, Bethany L.
    Ranapurwala, Shabbar I.
    Pettifor, Audrey E.
    Powers, Kimberly A.
    Delamater, Paul L.
    Fulcher, Naoko
    Pence, Brian W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2025, 34 (01)